Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine Augmentation of Habit Reversal Training for Tics
NCT02582515Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2015
- Primary completion
- Aug 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Tourette syndrome (TS) and chronic tic disorder comparing D-cycloserine + HRT with Placebo + HRT (2 arms). Primary endpoint: Hopkins Motor/Vocal Tic Scale at 1 week. Started Oct 2015; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Tourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on NCT02582515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582515.